Compounder

John Armitage

Net buying

Egerton Capital (UK) LLP — managed by John Armitage; US equity positions disclosed quarterly via SEC 13F

Data as of 2026-03-31 (filed 2026-05-13) · Source: SEC EDGAR

Portfolio value$9.01B2%)
Holdings24+1
Latest period2026-03-31
Top holdingVisa Inc
Portfolio overview

Egerton Capital (UK) LLP's most recent 13F filing, for the quarter ended 2026-03-31, reports 24 positions worth $9.01B. The top 5 holdings represent 44% of that value, a moderately concentrated portfolio.

The single largest position is Visa Inc at 13.8% of the portfolio, followed by Alphabet Inc at 11.0% and Moodys Corp at 7.5%.

Against the prior quarter, John Armitage opened 7 new positions, exited 6, added to 9, and trimmed 8. The largest new buy was Linde Plc. The most notable sale was the full exit from Boston Scientific Corp.

Across all 8 quarters on file, Visa Inc has appeared in every filing, as has Amazon Com Inc. Visa Inc currently ranks first by value.

A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.

High-conviction
Holdings

Sources· SEC EDGAR 13F as of 2026-05-13

Stay Updated

Curated 13F moves and valuation insights, straight to your inbox.